Michigan News Updates

Open-Angle Glaucoma Market

The Open-Angle Glaucoma market growth is driven by factors like increase in the prevalence of Open-Angle Glaucoma, investments in research and development, entry of emerging therapies during the study period 2019-2032.

The Open-Angle Glaucoma market report also offers comprehensive insights into the Open-Angle Glaucoma market size, share, Open-Angle Glaucoma epidemiology, emerging therapies, market drivers and barriers, ongoing clinical trials, key collaboration in the space, market uptake by key therapies and companies actively pushing Open-Angle Glaucoma market size growth forward. 

Some of the key highlights from the Open-Angle Glaucoma Market Insights Report:

• Several key pharmaceutical companies, including Aerie Pharmaceuticals, Sun Pharma Advanced Research Company Limited, Santen Pharmaceutical, Ube Industries,Bausch and Lomb, Alcon Research, Merck Sharp & Dohme Corp, Novartis, Alcon Research, Alcon Research, Allergan, and others, are developing novel products to improve the Open-Angle Glaucoma treatment outlook. 
• The total Open-Angle Glaucoma market size will include the market size of the potential upcoming therapies and current treatment regimens in the seven major markets.
• As per DelveInsight analysis, the Open-Angle Glaucoma market is anticipated to witness growth at a considerable CAGR

Strategise your business goals by understanding market dynamics @ Open-Angle Glaucoma Market Landscape

Open-Angle Glaucoma Overview 

Glaucoma is an eye disease that gradually steals vision. Open-Angle Glaucoma is the most common type of glaucoma. Open-Angle Glaucoma is a chronic, progressive, and irreversible multifactorial optic neuropathy that is characterized by an open angle of the anterior chamber, optic nerve head changes, progressive loss of peripheral vision, followed by central visual field loss. Glaucoma affects 70 million people worldwide and is the second leading cause of blindness. The underlying pathology of Open-Angle Glaucoma lies in the apoptosis of retinal ganglion cells. Open-Angle Glaucoma can be clinically evaluated using a variety of diagnostic tools including optic disc changes, visual field changes, and elevated intraocular pressure. The goal of treatment of Open-Angle Glaucoma is to prevent the progression of optic nerve head changes and also the prevention of deterioration of visual field.

Do you know the treatment paradigms for different countries? Download our Open-Angle Glaucoma Market Sample Report

Open-Angle Glaucoma Epidemiology Segmentation 

DelveInsight’s Open-Angle Glaucoma market report is prepared on the basis of epidemiology model. It offers comprehensive insights to the Open-Angle Glaucoma historical patient pools and forecasted Open-Angle Glaucoma patients. The report provides in-depth data of various subtypes and for the same epidemiology is segmented further. The Open-Angle Glaucoma Market report proffers epidemiological analysis for the study period 2019-32 in the 7MM segmented into:

• Open-Angle Glaucoma Prevalence 
• Age-Specific Open-Angle Glaucoma Prevalence 
• Gender-Specific Open-Angle Glaucoma Prevalence 
• Diagnosed and Treatable Cases of Open-Angle Glaucoma

Visit for more @ Open-Angle Glaucoma Epidemiological Insights

Open-Angle Glaucoma Treatment Market 

The Open-Angle Glaucoma market outlook of the report helps to build a detailed comprehension of the historic, current, and forecasted Open-Angle Glaucoma market trends by analyzing the impact of current Open-Angle Glaucoma therapies on the market, unmet needs, drivers and barriers, and demand for better technology.

This segment gives a thorough detail of Open-Angle Glaucoma market trend of each marketed drug and late-stage pipeline therapy by evaluating their impact based on the annual cost of therapy, inclusion and exclusion criteria’s, mechanism of action, compliance rate, growing need of the market, increasing patient pool, covered patient segment, expected launch year, competition with other therapies, brand value, their impact on the market and view of the key opinion leaders. The calculated Open-Angle Glaucoma market data are presented with relevant tables and graphs to give a clear view of the market at first sight.

According to DelveInsight, the Open-Angle Glaucoma market in 7MM is expected to witness a major change in the study period 2019-2032.

Open-Angle Glaucoma Key Companies

• Aerie Pharmaceuticals
• Sun Pharma Advanced Research Company Limited
• Santen Pharmaceutical/Ube Industries
• Bausch and Lomb
• Santen Pharmaceutical Co., Ltd.
• D.Western Therapeutics Institute (DWTI)/Kowa LTD.
• Alcon Research
• Merck Sharp & Dohme Corp.
• Novartis/Alcon Research
• Alcon Research, a Novartis company
• Allergan
• Laboratorios Sophia S.A de C.V.
• Perrigo Company
• Santen Pharmaceutical
• Chong Kun Dang Pharmaceutical
• Santen Inc./Ono Pharmaceutical
• Nicox Ophthalmics
• Sylentis
• Envisia Therapeutics
• Ocuphire Pharma
• Peregrine Ophthalmic

For more information, visit Open-Angle Glaucoma Market Analysis, Patient Pool, and Emerging Therapies

Scope of the Open-Angle Glaucoma Market Report:

• 11 Years Forecast
• 7MM Coverage 
• Descriptive overview of Open-Angle Glaucoma, causes, signs and symptoms, diagnosis, treatment
• Comprehensive insight into Open-Angle Glaucoma epidemiology in the 7MM
• Open-Angle Glaucoma marketed and emerging therapies 
• Open-Angle Glaucoma companies
• Open-Angle Glaucoma market drivers and barriers 

Key Questions Answered in the Open-Angle Glaucoma Market Report 2032:

• What was the Open-Angle Glaucoma market share distribution in 2019, and how would it appear in 2032?
• What is the total Open-Angle Glaucoma market size and the market size by therapy across the 7MM for the study period (2019-32)?
• What are the important findings from 7MM, and which country will have the greatest Open-Angle Glaucoma market size from 2019-32?
• During the study period (2019-2032), at what CAGR is the Open-Angle Glaucoma market projected to expand at 7MM?

Table of Contents:

1 Open-Angle Glaucoma Market Key Comprehensive Insights 

2 Open-Angle Glaucoma Market Report Introduction

3 Competitive Intelligence Analysis for Open-Angle Glaucoma

4 Open-Angle Glaucoma Market Analysis Overview at a Glance

5 Executive Summary of Open-Angle Glaucoma

6 Open-Angle Glaucoma Epidemiology and Market Methodology

7 Open-Angle Glaucoma Epidemiology and Patient Population

8 Open-Angle Glaucoma Patient Journey

9 Open-Angle Glaucoma Treatment Algorithm, Open-Angle Glaucoma Current Treatment, and Medical Practices

10 Key Endpoints in Open-Angle Glaucoma Clinical Trials

11 Open-Angle Glaucoma Marketed Therapies 

12 Open-Angle Glaucoma Emerging Therapies

13 Open-Angle Glaucoma: 7 Major Market Analysis

14 Attribute analysis

15 Access and Reimbursement Overview of Open-Angle Glaucoma

16 Open-Angle Glaucoma Market Key Opinion Leaders Reviews

18 Open-Angle Glaucoma Market Drivers

19 Open-Angle Glaucoma Market Barriers

20 SWOT Analysis

21 Disclaimer

22 DelveInsight Capabilities

23 About DelveInsight

Related Reports:

Open-Angle Glaucoma Epidemiology 2032

DelveInsight’s “Open-Angle Glaucoma – Epidemiology Forecast to 2032” report delivers an in-depth understanding of the disease, historical and forecasted Open-Angle Glaucoma epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Open-Angle Glaucoma Pipeline 2023

“Open-Angle Glaucoma Pipeline Insights, 2023” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Open-Angle Glaucoma market. A detailed picture of the Open-Angle Glaucoma pipeline landscape is provided, which includes the disease overview and Open-Angle Glaucoma treatment guidelines. 

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: +91-9650213330
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/